Menu
Recruiting NCT06503341

A Hospital-Based Registry of Preventive Cardiology Clinics

Observational Cardiovascular Morbidity Cardiovascular Risk Assesment Primary Prevention CVD

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Cardiovascular risk assesment.
Who it may be relevant to
Registry conditions: Cardiovascular Morbidity, Cardiovascular Risk Assesment, Primary Prevention CVD. Basic parameters: 18 years — 90 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention

Overview

More research is needed to articulate the most effective ways to use these tools as screening tests in cardiovascular risk assessments and how they ultimately affect CVD mortality and morbidity outcomes. Clinicians are encouraged to continue sharing decision-making with patients to combine their unique cardiovascular risk factors and develop a comprehensive, effective treatment plan.

Detailed description

Study Design: observational study Duration of Study: ongoing. Sample Size: All patients presenting to preventive cardiology clinics at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan..

Sampling Technique: Non-probability consecutive sampling Data Collection Procedure: Verbal informed consent will be obtained from all the patients regarding their participation in the study and publication of study findings while maintaining confidentiality. Consecutive patients presenting preventive cardiology clinics at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan, will be included in this registry. Demographic characteristics, physical examination, clinical history, risk modification, lab assessment, and ASCVD risk score at presentation and at every follow-up will be recorded using a structural questionnaire.

Data Analysis Procedure: The Tentative analysis plan uses collected data for research publications. The statistical package for social sciences (SPSS 21) will be used to analyze baseline characteristics. The Shapiro-Wilk test will be applied to check the hypothesis of normality for quantitative (continuous) variables. Descriptive statistics such as mean ± SD, median (IQR), skewness, maximum, and minimum will be calculated for quantitative (continuous) variables. Frequency and percentages will be calculated for categorical variables.

Interventions

  • Other Cardiovascular risk assesment
    ASCVD Score and WHO Cardiovascular Risk score.

Primary outcome measures

  • cardiovascular risk assesesment [Time frame: Ten years]
Secondary outcome measures (2)
  • Cardiovascular risk reduction [Time frame: Ten years]
  • Cardiovascular related deaths [Time frame: Ten years.]

Eligibility criteria

Inclusion criteria

  • All individuals attending the preventive cardiology clinics.

Exclusion criteria

  • • Individuals who refused to give consent.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

Pakistan · 1 center
  • National Institute of Cardiovascular Diseases — Karachi

Publications

  • Rauf R, Khan MN, Sial JA, Qamar N, Saghir T, Kazmi KA. Primary prevention of cardiovascular diseases among women in a South Asian population: a descriptive study of modifiable risk factors. BMJ Open. 2024 Nov 14;14(11):e089149. doi: 10.1136/bmjopen-2024-089149. PMID 39542488

Identifiers

NCT: NCT06503341 · IRB-20/2023

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗